Merck Drug Liability MDL To Go To Trial: Judge

Law360, New York (January 29, 2010, 7:05 PM EST) -- A federal judge has refused a bid by Merck & Co. Inc. to toss a bellwether case in multidistrict litigation over whether use of the osteoporosis drug Fosamax can cause degenerative jawbone disease, setting the case up for an April trial.

In an order entered Thursday, Judge John F. Keenan of the U.S. District Court for the Southern District of New York, who is overseeing the multidistrict litigation, said it was up to a jury to decide whether plaintiff Louise Maley's doctor would have continued to...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.